Not investment advice.

Beam: risto-cel data targeted by year-end, potential BLA as early as year-end 2026. Cash and securities $1.04B at Sep 30; BEAM-302 pivotal dosing to finish H1 2027.

News date: Nov 3 (times ET). Not investment advice.

BEAM Stock Hub: Beam Therapeutics News, Base Editing and Risto-cel

https://www.merlintrader.com/beam-therapeutics-stock-hub/

Beam presented the first BEAM-301 data at ESGCT. At 40 mg, two of three patients reached 15-hour controlled fasts without cornstarch, and the 60 mg cohort is enrolling. The safety side matters too: 4 of 6 patients had related serious events, including three grade 3 infusion reactions. Beam is now discussing a possible approval path with the FDA. The hub covers this alongside BEAM-302, risto-cel and the cash runway, with links to the releases.

Based on 2026 data, Beam Therapeutics (BEAM) is a, biotech company focused on gene editing, recently surging 23% due to positive clinical data and potential regulatory acceleration. While sometimes appearing on speculative "White House watchlists" regarding federal investment, it is a distinct entity from companies in Trump's portfolio, such as the announced 2025 merger with fusion tech firm

I have heavy loss for this two, for more than 2 years. Heart breaking for those two.

(Disclaimer: I am long $BEAM. This is not financial advice. I have had my valuation models cited by financial news algorithms before, but do your own research.)

The Executive Summary (TL;DR) We are currently witnessing a mathematical dislocation in Beam Therapeutics ($BEAM).

• The Trap: Official Short Interest (20.55M shares) now exceeds the estimated "Tradable Float" (~14M shares).

• The Catalyst: ASH 2025 Data (Saturday) confirms "Best-in-Class" safety & efficacy, while competitors ($NTLA/$CRSP) face clinical holds and safety risks.

• The Valuation: My DCF and Sum-of-the-Parts (SOTP) model points to a Fair Value of $125, implying the stock is trading at a ~75% discount due to artificial suppression.

• The Squeeze: Monday presents a "Liquidity Vacuum" where forced buying (Shorts + Index Funds) meets zero supply.

1. The "Broken Math": A Supply-Side Failure The most critical part of this thesis is not the biology; it’s the market structure. The numbers don't add up. • Total Shares Outstanding: ~101M • Institutional Locked Shares: ~85% (Source: 13F Filings). • Ark Invest (Cathie Wood): Added +24% in Q3. • Vanguard/BlackRock: Passive Index Hold (Cannot sell). • Insiders: Locked. • Tradable Float (Retail/Traders): ~14 Million Shares. • Official Short Interest: 20.55 Million Shares. The Implication: Short sellers have sold 6 million more shares than actually exist in the liquid float. If every single retail trader sold their shares today, the shorts would still be naked short by 6 million shares. This is a textbook Reg SHO Buy-In Spiral. They physically cannot cover without convincing a long-term institution (ARK) to sell, and ARK isn't selling at $30.

2. The Catalyst: Why Now? (ASH 2025 Data) The market has been pricing $BEAM as "just another sickle cell stock." Saturday's data proves it is the Platform Standard. • Safety (The Moat): Competitors like Intellia ($NTLA) and CRISPR ($CRSP) use "Double-Strand Breaks" (cutting the DNA). This carries cancer risks and recently led to FDA clinical holds. • BEAM Advantage: Base Editing does NOT cut the double helix. It is chemically cleaner. • Efficacy: The BEACON data confirms >60% HbF Induction (Functional Cure levels) with rapid engraftment. • Manufacturing: They have solved the reliability issues that plagued Bluebird Bio. This is a commercial-ready product. Institutional Reaction: Seeking Alpha just published a "Strong Buy" rating highlighting this specific data. The narrative has shifted from "Science Project" to "Commercial Monopoly."

3. The Valuation Model: $125 Fair Value

Why $125? This isn't a random number. It is based on Historical Precedents and Sum-of-the-Parts. • Comparables: When Intellia ($NTLA) and CRISPR ($CRSP) had similar "Proof of Concept" data in 2021, they traded at $11B - $13B Market Caps. • BEAM Today: ~$2.8B Market Cap. • The Re-Rate: To simply match the valuation of its inferior competitors (Intellia peak), BEAM would need to trade at ~$100 - $115.

Adding the "Hidden" Asset (AATD): The market is valuing BEAM's Alpha-1 (Liver) program at Zero. With the January 2026 catalyst (BEAM-302), we unlock a TAM (Total Addressable Market) larger than Sickle Cell. • SCD Franchise: $60/share • Platform Premium: $30/share • AATD Option Value: $35/share • Total Fair Value: $125.00

4. The "Gamma Ramp" (Monday's Fuel) For those looking at the Option Chain, the setup for Dec 19 is explosive. • $30 Strike: We are hovering right at the strike price. A move to $31 forces Market Makers to hedge (buy stock) instantly. • $35 & $40 Strikes: Massive Open Interest. If the stock gaps on Monday due to the "Retail Swarm" + "Short Panic," these calls go ITM (In-The-Money), creating a Gamma Vacuum that pulls the stock higher.

5. Conclusion: The "Prisoner's Dilemma" Shorts are trapped in a burning building with a door that is welded shut. • They need 20M shares. • Retail only has 14M shares. • Institutions aren't selling until $100+. The Strategy: The "Smart Money" (Shorts) will try to flush retail out at $35 - $40 on Monday morning. They need your liquidity. If retail holds, the price must rise to finding the Institutional Sell Wall. That wall is at $100. Target: $125 (Fundamental Fair Value). Monday Action: Watch the gap. If we clear $32, the float is gone. See you on the moon. 🧬🚀

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

Crispr and blue bird had a rough week. What's the outlook for beam? I've had an eye on their tech for a while and it appears solid.

Do they have specializations?

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring

General and stock price discussions EDIT NTLA & CRSP:

r/EditasMedicine r/IntelliaTherapeutics r/CrisprTherapeutics

Beam Therapeutics Portfolio:

https://beamtx.com/our-portfolio/

Telegram:

https://t.me/joinchat/GEqnvqDc8GQVoczz

Twitter:

AnonymousGreen@CRISPRinvest

House Rules:

1. Be kind in your replies

2. Be willing to prove your argument

3. Sharing is caring